A Study in Participants With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1369 participants.
Also called NCT01468987
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 1,369 participants
- Sponsor
- Registry
-
NCT01468987 -
2011-001254-29
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Brazil, Croatia, Czechia, Denmark, Germany, Greece, Hungary, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russia, Slovakia, Spain, Taiwan, Türkiye, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01468987. Randomized; quadruple masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2013-08 (actual). Results posted on 2018-04-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study in Participants With Type 2 Diabetes Mellitus
- Acronym
- IMAGINE 4
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- LY2605541
- Intervention (Drug)
- Insulin Glargine
- Intervention (Drug)
- Insulin Lispro
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01468987- Content hash
200bc69c624bf3da218eaa16af85011bac5a01d37162d5d8145da7f67a76e770